Impact of Sleeve Gastrectomy on Psychiatric Medication Use and Symptoms.

ABSTRACT:

Background

Sleeve gastrectomy (SG) has become the primary bariatric surgery procedure in the U.S. Over 50% of people presenting for surgery have psychiatric diagnoses. The study purpose was to evaluate change in anxiety and depression symptoms and medication use after SG.

Methods

Subjects completing SG with a diagnosis of anxiety and/or depression treated with medication were retrospectively identified from the electronic medical record (EMR) of Synergy Bariatrics, a department of the Erie County Medical Center. Phone outreach was made to complete seven-point global impression of change scale classifying symptom improvement or worsening in the 3- to 6-month postoperative period. Improvement or worsening was defined as either all reported symptoms improving or worsening or ≥1

SUBMITTER: Monte SV 

PROVIDER: S-EPMC6205308 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature